Does a Transcriptionally Active HPV Infection Affect the Invasiveness of Pituitary Neuroendocrine Tumors? A Case Series Study of 60 Patients in Krakow, Poland
Open Access
Abstract
Background/Objective: Pituitary neuroendocrine tumors (PITNETs) often show a tendency towards invasive behavior, i.e., an invasion towards the cavernous sinuses or destruction of the sella turcica. In the present study, we analyzed whether a transcriptionally active HPV infection affects the invasiveness of pituitary tumors. Methods: Sixty patients with different phenotypes of PITNETs who underwent neurosurgery were studied. The obtained postoperative material was analyzed histopathologically. For each patient, formalin-fixed paraffin-embedded blocks were cut into ultra-thin slices and two to three of them were designated for DNA extraction, while one was used for histological slides. Based on the isolated DNA, the presence of DNA from individual HPV types was determined by the real-time detection polymerase chain reaction using the REALQUALITY RQ-Multi HPV Detection reagent kit (AB ANALITICA, Italy). P16 protein expression was assessed by immunohistochemical staining on the histological slides. A transcriptionally active infection with individual HPV types was distinguished when HPV DNA and P16 protein overexpression were detected simultaneously for a given tumor. Results: In the group of the 60 analyzed PITNETs, a transcriptionally active high-risk HPV infection was detected in a subset of 11 tumors (18.3%). This infection was associated with a significantly lower probability of tumor invasiveness, measured on both the Knosp (OR = 0.11, 95% CI: 0.02–0.58) and Hardy scales (OR = 0.12 95% CI: 0.024–0.56). Conclusions: Further studies are needed to confirm the prevalence of transcriptionally active HPV infections in pituitary adenomas and the role of these infections in the invasiveness of pituitary tumors.Keywords
Funding Information
- National Science Centre, Poland (2023/07/X/NZ5/00280)
This publication has 25 references indexed in Scilit:
- Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular featuresActa Neuropathologica, 2024
- Overview of the 2022 WHO Classification of Pituitary Adenomas/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and PerspectivesCurrent Medical Science, 2022
- Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomasJournal of Neuro-Oncology, 2020
- Immune Landscape of Viral- and Carcinogen-Driven Head and Neck CancerImmunity, 2020
- Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomasActa Neurochirurgica, 2019
- The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary AdenomasEndocrine Pathology, 2019
- New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factorsBrain Tumor Pathology, 2018
- CD8 + T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancerEuropean Journal of Cancer, 2016
- Systemic and local human papillomavirus 16‐specific T‐cell immunity in patients with head and neck cancerInternational Journal of Cancer, 2011
- Nonfunctioning Pituitary Tumors and Pituitary IncidentalomasEndocrinology and Metabolism Clinics of North America, 2008